Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05708014 · ClinicalTrials.gov registry record · NA
Personalized Prevention for Couples: A 16-month Digital RCT
A NA study, sponsored by Florida International University.
- Completed
- Registry status
- NA
- Development phase
- 778
- Enrollment target
NCT05708014: Completed NA study, sponsored by Florida International University.
NCT05708014 is a NA study that has completed, run by Florida International University. The registered enrollment target is 778 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (45% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05708014, a NA study, has completed, sponsored by Florida International University.
- COMPLETED
- Registry status
- NA
- Development phase
- 778 participants
- Enrollment target
Study Summary
This couples-based, digital health intervention project is serostatus neutral and seeks to determine efficacy for: a) use and adherence to evidence-based HIV/STI prevention-care strategies; b) creation and adherence to a tailored prevention-care plan; c) creation and adherence to a tailored sexual agreement; and d) improvements in other relationship dynamics among male couples who are in a relationship (defined as greater than 3 months or more).
Primary Outcome
Participants will be asked to provide sample to test for HIV at baseline and 16-months, using at-home self-collection test kits. Count: New HIV and STI diagnosis via biomedical testing at follow-up occurring 16 months after baseline randomization.
Interventions
- BEHAVIORAL Intervention LuvHub
- BEHAVIORAL Waitlist Control LuvHub
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 778 participants |
| Start Date | 2023-01-11 |
| Est. Completion | 2025-08-25 |
| Phase | NA |
What the finished NCT05708014 record still lists
NCT05708014 is an interventional study that assigns participants to a tested intervention. The registered 778 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (45% lower).
The record links to 0 conditions, and to 2 interventions - of which Intervention LuvHub is the first listed.
NCT05708014 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05708014 about?
NCT05708014 is a clinical study titled "Personalized Prevention for Couples: A 16-month Digital RCT". This couples-based, digital health intervention project is serostatus neutral and seeks to determine efficacy for: a) use and adherence to evidence-based HIV/STI prevention-care strategies; b) creation and adherence to a tailored prevention-care plan; c) creation and adherence to a tailored sexual a...
What is the current status of trial NCT05708014?
This trial is currently completed. It is a NA study. The enrollment target is 778 participants. The study started on 2023-01-11. Estimated completion is 2025-08-25.
What interventions are being tested in trial NCT05708014?
The interventions under investigation include: Intervention LuvHub (BEHAVIORAL), Waitlist Control LuvHub (BEHAVIORAL).
Who is sponsoring clinical trial NCT05708014?
This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05708014's enrollment target sits among peer trials
778 142nd of 2000 higher than 1,859 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06841679 · 778 participants · Phase 2
Utidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT05642611 · 777 participants · Phase 3
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy
- NCT05046613 · 780 participants
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
- NCT05100862 · 780 participants · Phase 3
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI